| Subcribe via RSS



Roche’s investigational drug improves vision in patients with RVO

July 31st, 2009

BASEL,A Switzerland Patients with vision loss due to a disease that causes swelling of the retina experienced improvements when treated with an investigational biotech drug from Roche, the Swiss drug maker said Thursday.

Original post by Drug Store News


(click on the author/publication link above to see full post)
This entry was posted on Friday, July 31st, 2009 at 2:48 pm. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.

Comments are closed.

«
»